PERPHENAZINE TAB 4MG 4 MG
PERPHENAZINE : 4 MG · DIN 00456047 · D.C. LABS LIMITED
Health Canada status: CANCELLED POST MARKET
What is PERPHENAZINE TAB 4MG?
PERPHENAZINE TAB 4MG 4 MG contains PERPHENAZINE : 4 MG. It is listed in the Health Canada Drug Product Database under DIN 00456047, held by D.C. LABS LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Jul-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00456047 |
|---|---|
| Brand name | PERPHENAZINE TAB 4MG |
| Generic / active ingredient | PERPHENAZINE : 4 MG |
| Manufacturer | D.C. LABS LIMITED |
| Strength | 4 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AB03 PERPHENAZINE |
| AHFS class | 28:16.08.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Jul-2003 |
| Original market date | 1979-12-31 00:00:00 |
Is PERPHENAZINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 12 Jun 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N05AB03 PERPHENAZINE. 4 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PERPHENAZINE | 16 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00335096 |
| PERPHENAZINE | 2 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00335134 |
| PERPHENAZINE | 4 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00335126 |
| PERPHENAZINE | 8 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00335118 |
| PERPHENAZINE 16 TAB | 16 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563722 |
| PERPHENAZINE 2 TAB 2MG | 2 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563757 |
| PERPHENAZINE 8 TAB 8MG | 8 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563730 |
| PERPHENAZINE TAB 2MG | 2 MG | TABLET | D.C. LABS LIMITED | CANCELLED POST MARKET | DIN 00456039 |
| PERPHENAZINE TAB 4MG | 4 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00563749 |
| PHENAZINE 16 TAB | 16 MG | TABLET | ICN CANADA LTD. | CANCELLED POST MARKET | DIN 00294802 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.